Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up
- PMID: 31727428
- DOI: 10.1016/j.ophtha.2019.10.002
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 3 Years of Follow-up
Abstract
Purpose: To report 3-year results of the Primary Tube Versus Trabeculectomy (PTVT) Study.
Design: Unmasked multicenter randomized clinical trial.
Participants: Two hundred forty-two eyes of 242 patients with medically uncontrolled glaucoma and no previous incisional ocular surgery, including 125 in the tube group and 117 in the trabeculectomy group.
Methods: Patients were enrolled at 16 clinical centers and were assigned randomly to treatment with a tube shunt (350-mm2 Baerveldt glaucoma implant) or trabeculectomy with mitomycin C (MMC; 0.4 mg/ml for 2 minutes).
Main outcome measures: The primary outcome measure was the rate of surgical failure, defined as intraocular pressure (IOP) of more than 21 mmHg or reduced less than 20% from baseline, IOP of 5 mmHg or less, reoperation for glaucoma, or loss of light perception vision. Secondary outcome measures included IOP, glaucoma medical therapy, visual acuity, and surgical complications.
Results: The cumulative probability of failure after 3 years of follow-up was 33% in the tube group and 28% in the trabeculectomy group (P = 0.17; hazard ratio, 1.39; 95% confidence interval, 0.9-2.2). Mean ± standard deviation IOP was 14.0±4.2 mmHg in the tube group and 12.1±4.8 mmHg in the trabeculectomy group at 3 years (P = 0.008), and the number of glaucoma medications was 2.1±1.4 in the tube group and 1.2±1.5 in the trabeculectomy group (P < 0.001). Serious complications requiring reoperation or producing loss of 2 or more Snellen lines developed in 3 patients (2%) in the tube group and 9 patients (8%) in the trabeculectomy group (P = 0.11).
Conclusions: There was no significant difference in the rate of surgical failure between the 2 surgical procedures at 3 years. Trabeculectomy with MMC achieved lower IOP with use of fewer glaucoma medications compared with tube shunt surgery after 3 years of follow-up in the PTVT Study. Serious complications producing vision loss or requiring reoperation occurred with similar frequency after both surgical procedures.
Copyright © 2019 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Comment in
-
Re: Gedde et al.: Treatment outcomes in the Primary Tube Versus Trabeculectomy (PTVT) study after 3 years of follow-up (Ophthalmology. 2020;127:333-345).Ophthalmology. 2020 Jul;127(7):e44-e45. doi: 10.1016/j.ophtha.2020.02.030. Ophthalmology. 2020. PMID: 32564820 No abstract available.
-
Reply.Ophthalmology. 2020 Jul;127(7):e45-e46. doi: 10.1016/j.ophtha.2020.02.033. Ophthalmology. 2020. PMID: 32564821 No abstract available.
-
Re: Gedde et al.: Treatment outcomes in the Primary Tube Versus Trabeculectomy study after 3 years of follow-up (Ophthalmology. 2020;127:333-345).Ophthalmology. 2020 Sep;127(9):e79. doi: 10.1016/j.ophtha.2020.04.013. Ophthalmology. 2020. PMID: 32828202 No abstract available.
-
Reply.Ophthalmology. 2020 Sep;127(9):e79-e80. doi: 10.1016/j.ophtha.2020.04.014. Ophthalmology. 2020. PMID: 32828203 No abstract available.
-
Re: Gedde et al.: Treatment outcomes in the Primary Tube Versus Trabeculectomy (PTVT) study after 3 years of follow-up (Ophthalmology. 2020;127:333-345).Ophthalmology. 2020 Sep;127(9):e80-e81. doi: 10.1016/j.ophtha.2020.04.024. Ophthalmology. 2020. PMID: 32828204 No abstract available.
-
Reply.Ophthalmology. 2020 Sep;127(9):e81-e82. doi: 10.1016/j.ophtha.2020.04.025. Ophthalmology. 2020. PMID: 32828205 No abstract available.
Similar articles
-
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.Ophthalmology. 2018 May;125(5):650-663. doi: 10.1016/j.ophtha.2018.02.003. Epub 2018 Feb 21. Ophthalmology. 2018. PMID: 29477688 Clinical Trial.
-
Three-year follow-up of the tube versus trabeculectomy study.Am J Ophthalmol. 2009 Nov;148(5):670-84. doi: 10.1016/j.ajo.2009.06.018. Epub 2009 Aug 11. Am J Ophthalmol. 2009. PMID: 19674729 Clinical Trial.
-
Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 5 Years of Follow-up.Ophthalmology. 2022 Dec;129(12):1344-1356. doi: 10.1016/j.ophtha.2022.07.003. Epub 2022 Jul 12. Ophthalmology. 2022. PMID: 35835337 Free PMC article. Clinical Trial.
-
Results from the Primary Tube Versus Trabeculectomy Study and translation to clinical practice.Curr Opin Ophthalmol. 2023 Mar 1;34(2):129-137. doi: 10.1097/ICU.0000000000000928. Epub 2022 Nov 9. Curr Opin Ophthalmol. 2023. PMID: 36730686 Free PMC article. Review.
-
Review of results from the Tube Versus Trabeculectomy Study.Curr Opin Ophthalmol. 2010 Mar;21(2):123-8. doi: 10.1097/ICU.0b013e3283360b68. Curr Opin Ophthalmol. 2010. PMID: 20040872 Free PMC article. Review.
Cited by
-
PreserFlo MicroShunt versus trabeculectomy: an updated meta-analysis and systematic review.Graefes Arch Clin Exp Ophthalmol. 2024 Oct 12. doi: 10.1007/s00417-024-06649-w. Online ahead of print. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 39394492 Review.
-
[Glaucoma drainage devices in patients following injector-assisted implantation of an artificial iris into the ciliary sulcus : Video article].Ophthalmologie. 2024 Nov;121(11):920-923. doi: 10.1007/s00347-024-02120-7. Epub 2024 Sep 25. Ophthalmologie. 2024. PMID: 39320479 German.
-
Evaluating the Safety and Efficacy of a Novel Glaucoma Drainage Device in High-Risk Adult Glaucoma Patients: A One-Year Pilot Study.J Clin Med. 2024 Aug 23;13(17):4996. doi: 10.3390/jcm13174996. J Clin Med. 2024. PMID: 39274211 Free PMC article.
-
Systematic Literature Reviews Comparing the Long-Term Safety Outcomes for the Port Delivery System with Ranibizumab (PDS) Versus Other Ocular Implants.Ophthalmol Ther. 2024 Sep;13(9):2303-2329. doi: 10.1007/s40123-024-01001-1. Epub 2024 Aug 1. Ophthalmol Ther. 2024. PMID: 39090513 Free PMC article. Review.
-
Predicting a reduction in intraocular pressure in glaucoma patients in the early period after a trabeculectomy: Development and assessment of a new predictive nomogram.Front Ophthalmol (Lausanne). 2022 Oct 27;2:987742. doi: 10.3389/fopht.2022.987742. eCollection 2022. Front Ophthalmol (Lausanne). 2022. PMID: 38983537 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
